title: Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma.
authors.affiliation: Department of Medicine (FJK) and Clinical Trials Office (AMI), University of Florida Cancer Center; Department of Radiology (WD), Department of Radiation Oncology (WMM), and Department of Pathology, Immunology, and Laboratory Medicine (RWA), University of Florida College of Medicine, Gainesville, FL. fkaye@ufl.edu.
authors.forename: Frederic J
authors.initials: FJ
authors.lastname: Kaye
authors.affiliation: Department of Medicine (FJK) and Clinical Trials Office (AMI), University of Florida Cancer Center; Department of Radiology (WD), Department of Radiation Oncology (WMM), and Department of Pathology, Immunology, and Laboratory Medicine (RWA), University of Florida College of Medicine, Gainesville, FL.
authors.forename: Alison M
authors.initials: AM
authors.lastname: Ivey
authors.affiliation: Department of Medicine (FJK) and Clinical Trials Office (AMI), University of Florida Cancer Center; Department of Radiology (WD), Department of Radiation Oncology (WMM), and Department of Pathology, Immunology, and Laboratory Medicine (RWA), University of Florida College of Medicine, Gainesville, FL.
authors.forename: Walter E
authors.initials: WE
authors.lastname: Drane
authors.affiliation: Department of Medicine (FJK) and Clinical Trials Office (AMI), University of Florida Cancer Center; Department of Radiology (WD), Department of Radiation Oncology (WMM), and Department of Pathology, Immunology, and Laboratory Medicine (RWA), University of Florida College of Medicine, Gainesville, FL.
authors.forename: William M
authors.initials: WM
authors.lastname: Mendenhall
authors.affiliation: Department of Medicine (FJK) and Clinical Trials Office (AMI), University of Florida Cancer Center; Department of Radiology (WD), Department of Radiation Oncology (WMM), and Department of Pathology, Immunology, and Laboratory Medicine (RWA), University of Florida College of Medicine, Gainesville, FL.
authors.forename: Robert W
authors.initials: RW
authors.lastname: Allan
mesh_terms: D000328:Adult; D001741:Black or African American / Q000706:statistics & numerical data; D000564:Ameloblastoma / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D057176:Compassionate Use Trials; D018698:Glutamic Acid; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008339:Mandibular Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D058990:Molecular Targeted Therapy / Q000379:methods*; D009154:Mutation; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging / Q000188:drug therapy*; D009367:Neoplasm Staging; D010091:Oximes / Q000008:administration & dosage / Q000009:adverse effects; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D011728:Pyridones / Q000008:administration & dosage / Q000009:adverse effects; D011744:Pyrimidinones / Q000008:administration & dosage / Q000009:adverse effects; D011859:Radiography; D016896:Treatment Outcome; D014633:Valine
chemical_list: D007093:Imidazoles; D010091:Oximes; D011728:Pyridones; D011744:Pyrimidinones; C560077:trametinib; D018698:Glutamic Acid; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D014633:Valine; C561627:dabrafenib